IP Verse

Aav-Mediated Gene Therapy Restoring The Otoferlin Gene

Patent No. EP3911354 (titled "Aav-Mediated Gene Therapy Restoring The Otoferlin Gene") was filed by Centre National DE LA Recherche Scientifique Cnrs on Jan 20, 2020. The application was issued on Apr 3, 2024.

Patent Summary

Patent Family

Patent Family

Patent Oppositions (4)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
MICHALSKI HUTTERMANN & PARTNER PATENTANWALTE MBBApr 19, 2024-
POHLMANApr 19, 2024POHLMAN
WEICKMANN & WEICKMANNApr 18, 2024-
REGENERON PHARMACEUTICALSApr 16, 2024CARPMAELS & RANSFORD

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP3911354

CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE CNRS
Application Number
EP20701951A
Filing Date
Jan 20, 2020
Status
Granted And Under Opposition
Jun 16, 2023
Publication Date
Apr 3, 2024
External Links
Slate, Register , Google Patents